SPC
MYOV

Sigma Planning Corp’s Myovant Sciences Ltd. MYOV Stock Holding History

Sigma Planning Corp’s Portfolio MYOV Stock Details MYOV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-10,000
Closed -$155K – 1133
2019
Q4 		$155K Buy
+10,000
New +$101K 0.01% 993

Other funds holding MYOV

Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
NCM
NovaQuest Capital Management Raleigh, North Carolina $54.3M AUM 163.39% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
Lord, Abbett & Co
Lord, Abbett & Co Jersey City, New Jersey $30.6B AUM 57.44% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
OM
Opaleye Management Boston, Massachusetts $759M AUM 124.8% 1-Year Est. Return

Sigma Planning Corp's MYOV Position: Q1 2020 in Review

Sigma Planning Corp sold out of Myovant Sciences Ltd. (MYOV) in Q1 2020, closing a stake of 10,000 shares — an estimated $155K sold.

Sigma Planning Corp first reported a position in MYOV in Q4 2019 and held it in 1 quarter. The position peaked at $155K in Q4 2019. 75 funds tracked by Wall St. Rank hold MYOV as of Q1 2020.

  • Sigma Planning Corp reported no remaining Myovant Sciences Ltd. position as of Q1 2020 after selling out during the quarter.
  • Sigma Planning Corp sold 10,000 Myovant Sciences Ltd. shares in Q1 2020, an estimated $155K.
  • Sigma Planning Corp first reported a position in Myovant Sciences Ltd. in Q4 2019 and held it in 1 quarter.
  • Sigma Planning Corp's Myovant Sciences Ltd. position peaked at $155K in Q4 2019.
  • 75 funds tracked by Wall St. Rank held Myovant Sciences Ltd. as of Q1 2020.

Based on Sigma Planning Corp's 13F filing for Q1 2020, filed 1 May 2020.